CASE STUDY 73479 Meet the expert Rich Rogers discusses his vision of what the future may hold for the multi-attribute method (MAM) in the biopharmaceutical industry The MAM Consortium was established to enable the biopharmaceutical industry to leverage MAM as a process development tool for better process understanding. This effort will pave the way to the ultimate goal: Introducing MAM in a quality control laboratory as a product release method, replacing select traditional analytical methods with a single MAM assay. The MAM Consortium is a forum where representatives of biopharmaceutical companies, instrument and software vendors, contract manufacturing organizations, contract research organizations, and regulatory agencies connect to discuss ways to leverage MAM in the ind

Join for free to read